BRIEF published on 08/15/2026 at 00:55, 2 months 27 days ago Revive Therapeutics Grants 15.5 Million Stock Options Stock Options Life Sciences Biodefense Pandemic Preparedness Revive Therapeutics
PRESS RELEASE published on 08/15/2026 at 00:50, 2 months 27 days ago Revive Therapeutics Reports Grant of Options Revive Therapeutics Ltd. authorized the grant of 15,500,000 incentive stock options to key team members. The options aim to drive performance and incentivize excellence in advancing corporate objectives Stock Options Incentive Pandemic Preparedness Revive Therapeutics Ltd. Biodefence
BRIEF published on 08/12/2026 at 14:00, 2 months 29 days ago Revive Therapeutics annonce des résultats d'étude positifs sur la bucillamine pour l'exposition aux agents neurotoxiques Biodefense Bucillamine Revive Therapeutics Recherche Sur Les Agents Neurotoxiques Étude Du DRDC
BRIEF published on 08/12/2026 at 14:00, 2 months 29 days ago Revive Therapeutics Announce Positive Study Results on Bucillamine for Nerve-Agent Exposure Bucillamine Revive Therapeutics Nerve-agent Research DRDC Study Biodefence
PRESS RELEASE published on 08/12/2026 at 13:55, 2 months 29 days ago Revive Therapeutics Reports Positive Results from DRDC Bucillamine Nerve-Agent Research Study Revive Therapeutics announces positive results from DRDC research study on bucillamine in nerve-agent exposure model, showing preservation of GABA receptors. Further studies planned Bucillamine Revive Therapeutics DRDC Research Study Nerve-agent Exposure GABA Receptors
BRIEF published on 07/16/2026 at 00:45, 3 months 26 days ago Revive Therapeutics finalise la première tranche de placements privés Placement Privé Sciences De La Vie Actions Et Bons De Souscription Initiative De Financement Revive Therapeutics
BRIEF published on 07/16/2026 at 00:45, 3 months 26 days ago Revive Therapeutics Completes First Tranche of Private Placement Private Placement Life Sciences Shares And Warrants Funding Initiative Revive Therapeutics
PRESS RELEASE published on 07/16/2026 at 00:40, 3 months 26 days ago Revive Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement Revive Therapeutics Ltd. closes the first tranche of non-brokered private placement, raising $246,920 for infectious diseases and medical countermeasures research and development Private Placement Research And Development Medical Countermeasures Infectious Diseases Revive Therapeutics Ltd.
BRIEF published on 06/26/2026 at 22:20, 4 months 14 days ago Revive Therapeutics propose un placement privé pour lever 1 million de dollars Investissement Actions Placement Privé Sciences De La Vie Revive Therapeutics
BRIEF published on 06/26/2026 at 22:20, 4 months 14 days ago Revive Therapeutics Proposes Private Placement to Raise $1 Million Private Placement Shares Life Sciences Investment Revive Therapeutics
Published on 11/11/2026 at 03:30, 5 hours 28 minutes ago CoTec Holdings Corp. Files Third Quarter Financial Statements and MD&A and Provides Market Commentary
Published on 11/11/2026 at 00:40, 8 hours 18 minutes ago Upgraded Tunkillia MRE Validates Optimised Scoping Study
Published on 11/10/2026 at 23:30, 9 hours 28 minutes ago CCL Industries Announces 2026 Third Quarter Results
Published on 11/10/2026 at 23:00, 9 hours 58 minutes ago Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/10/2026 at 23:00, 9 hours 58 minutes ago Battery X Metals Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/11/2026 at 08:31, 27 minutes ago Delivery Hero SE: Notice to the Bondholders of the EUR 500 million Convertible Bonds due 2029 (ISIN DE000A3MP437 – Common Code 238511097 – German Securities Code (WKN) A3MP43)
Published on 11/11/2026 at 08:30, 27 minutes ago Delivery Hero SE: Notice to the Bondholders of the EUR 1,000 million Convertible Bonds due 2030 (ISIN DE000A30V5R1 – Common Code 258943848 – German Securities Code (WKN) A30V5R)
Published on 11/11/2026 at 08:30, 28 minutes ago Delivery Hero SE: Notice to the Bondholders of the EUR 750 million Convertible Bonds due 2028 (ISIN DE000A3H2WQ0 – Common Code 220637387 – German Securities Code (WKN) A3H2WQ)
Published on 11/11/2026 at 08:30, 28 minutes ago aap Implantate AG: Management Board refines 2026 forecast and provides first outlook for 2027 – Ambition 2030: Revenue of at least EUR 21 million with an EBITDA margin of 17.5% to 22.5%
Published on 11/11/2026 at 08:30, 28 minutes ago Delivery Hero SE: Notice to the Bondholders of the EUR 875 million Convertible Bonds due 2027 (ISIN DE000A254Y92 – Common Code 210751831 – German Securities Code (WKN) A254Y9)
Published on 11/10/2026 at 18:00, 14 hours 58 minutes ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 15 hours 13 minutes ago Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:35, 15 hours 23 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 15 hours 26 minutes ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
